GU Cancers 2020 | Toxicity in frontline RCC therapy

Name: Toxicity in frontline RCC therapy
Uploaded: 2020-02-16T19:36:50Z
Description: Elizabeth Plimack, MD, MS, Fox Chase Cancer Center, Philadelphia, PA, discusses the toxicity profiles and side effect management of first-line treatment options in renal cell carcinoma (RCC). This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.

Elizabeth Plimack • 16 Feb 2020

GU Cancers 2020

Genitourinary Cancer Kidney Cancer

Elizabeth Plimack, MD, MS, Fox Chase Cancer Center, Philadelphia, PA, discusses the toxicity profiles and side effect management of first-line treatment options in renal cell carcinoma (RCC). This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.